Larry J Copeland
4PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 12, 2025
Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026).Brian M Slomovitz, S John Weroha, Wei Deng
|Oct 17, 2022
Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study.Benoit You, Christopher Purdy, Larry J Copeland
|Jun 27, 2022
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.Larry J Copeland, Mark F Brady, Robert A Burger
|Jan 10, 2022
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.Matthew A Powell, Virginia L Filiaci, Martee L Hensley
Pageof 1
Frequent Collaborators
3 joint publications
Krishnansu S Tewari
3 joint publications
David S Miller
2 joint publications
David Mutch
2 joint publications
Robert L Coleman
2 joint publications
David M O'Malley
1 joint publications
Matthew A Powell
1 joint publications
Virginia L Filiaci
1 joint publications
Kathleen N Moore
1 joint publications
Angeles A Secord
1 joint publications
Paul A DiSilvestro
